Due diligence in human health for AXA Private Equity

Situation

• Axa Private Equity had been mandated to support an MBO based on a French portfolio of human products
• Axa Private equity required the assistance of Bionest on critical issues

1. Product portfolio diligence
2. Business case development and validation
3. Potential upside and management assessment

Bionest Contribution

• Bionest developed a tailored due diligence process for pharmaceutical products…

1. In-depth analysis of products and related markets
2. Sales projections, anticipation of regulatory measures impacting on sales and margins

• ...and validated Newco model

1. Business model assessment and management evaluation
2. Business case and exit scenario

Key Results

• Strong inputs to commitment decision…
• …based on a very results-oriented methodology